News

PhD students Henry Thomas and Claudia Pachinger have been awarded the uni:docs Fellowships. Congratulations also to Katharina Siess and Michael…

16 Oct'19

On Thursday the 5th September 2019, the Vienna BioCenter Postdoc Symposium on Publishing Models took place. The reason for organizing it was the…

07 Oct'19

The immune system relies on B cells and their ability to make antibodies against an extremely broad range of pathogens. This broad responsiveness…

01 Oct'19

The Medical University of Vienna has nominated Anete Romanauska as Researcher of the Month. Born in Latvia, she studied Biology in Riga and later in…

30 Sep'19

Valneva announced that it has completed patient recruitment of the Phase 2 studies for its Lyme disease vaccine candidate, VLA15.

26 Sep'19

Protein Kinase D (PKD) is an enzyme at the heart of many cellular functions. By modifying other proteins, it controls the trafficking of essential…

19 Sep'19

Eucodis developed and patented a catalase as a novel neutralizer in environmental monitoring media and offers either a collaboration or OEM supply of…

19 Sep'19

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,…

16 Sep'19

Emily Bayer of Columbia University, Mohamed El-Brolosy of the Max Planck Institute for Heart and Lung Research, and Justin Silpe of Princeton…

16 Sep'19

Visit the Vienna BioCenter on Friday, 11 October 2019 and learn about research opportunities at our campus.

11 Sep'19

Alejandro Burga, group leader at IMBA - Institute of Molecular Biotechnology, has been awarded the Starting Grant of the European Research Council,…

11 Sep'19

An ERC Proof of Concept Grant has been awarded to IMP Group Leader Johannes Zuber. He will use the funds towards the development of a diagnostic…

Four PhD fellowships for Max Perutz Labs students

VBC postdoc symposium on publishing models

IMP scientists discover a mechanism that controls autoimmunity

Anete Romanauska is Researcher of the Month at the Medical University of Vienna

Valneva Completes Recruitment for Phase 2 Studies of its Lyme Disease Vaccine Candidate VLA15

It takes two to tango: using the ubiquitin fold to turn on secretion

Novel Catalase for complete neutralization of H2O2 in agar plates

Valneva Confirms Delisting from the Vienna Stock Exchange

IMP and Birnstiel Foundation honour three young scientists with research award

Campus Open Day: 11 October 2019

ERC Starting Grant for IMBA Group Leader Alejandro Burga

ERC funds to help predict drug responses